Page last updated: 2024-08-25

oxazolidin-2-one and isoniazid

oxazolidin-2-one has been researched along with isoniazid in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.26)18.7374
1990's0 (0.00)18.2507
2000's6 (31.58)29.6817
2010's10 (52.63)24.3611
2020's2 (10.53)2.80

Authors

AuthorsStudies
Gorecki, DK; Peesker, SJ; Wood, JD1
González-Lahoz, JM; Laguna, F; Moreno, V; Valencia, ME1
Cynamon, MH; DeStefano, MS; Monica, BJ; Shoen, CM; Sklaney, MR; Slee, AM1
Rao, M; Rattan, A; Singhal, S; Sood, R1
Fatma, T; Malhotra, S; Rao, M; Rattan, A; Sood, R; Upadhyay, DJ1
Boom, WH; Debanne, SM; Dietze, R; Eisenach, K; Hadad, DJ; Johnson, DF; Johnson, JL; Maciel, EL; McGee, B; Molino, LP; Palaci, M; Peloquin, CA1
Bilgin, K; Coban, AY; Durupinar, B; Uzun, M1
Angulo-Barturen, I; Beltrán, M; Cáceres, N; Cardona, PJ; García, JI; García-Bustos, JF; Rullas, J1
Alffenaar, JW; de Neeling, H; Simons, S; van de Kasteele, PJ; van der Laan, T; van der Werf, TS; van Soolingen, D1
Barbedo, J; Centis, R; D'Ambrosio, L; Diogo, N; Fernandes, L; Lange, C; Migliori, GB; Raymundo, E; Sotgiu, G; Villar, M1
Amoabeng, O; Andries, K; Mdluli, KE; Minkowski, A; Nuermberger, EL; Peloquin, CA; Taylor, D; Wallis, RS; Williams, K1
Chang, KC; Leung, CC; Tam, CM; Yew, WW1
Conradie, F; Evans, D; Louw, R; Mabaso, S; Mabiletsa, T; Sefoka, M; Van Rie, A1
Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y1
Nair, SG; Patel, DB; Patel, HD; Rathwa, SK; Vasava, MS1
Fattorini, L; Giannoni, F; Iacobino, A; Pardini, M; Piccaro, G1
Martins Dos Santos, VAP; Rienksma, RA; Schaap, PJ; Suarez-Diez, M1
Alsultan, A; Byun, MK; Cho, I; Choi, H; Geiter, L; Joh, JS; Kang, JY; Kang, YS; Kim, H; Kim, JS; Kim, JW; Kim, SJ; Kim, SK; Kim, TH; Kim, YH; Lee, SH; Lim, HS; Mok, J; Park, HJ; Park, YB; Shen, X; Shim, TS; Yang, J1
Kamoshita, F; Karaushi, H; Mitsutake, K; Miyawaki, Y; Seki, M; Watanabe, N1

Reviews

2 review(s) available for oxazolidin-2-one and isoniazid

ArticleYear
WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Acetamides; Adult; Antitubercular Agents; beta-Lactams; Clofazimine; Cohort Studies; Databases, Bibliographic; Female; Fluoroquinolones; Humans; Isoniazid; Linezolid; Macrolides; Male; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2013
Development of new drug-regimens against multidrug-resistant tuberculosis.
    The Indian journal of tuberculosis, 2019, Volume: 66, Issue:1

    Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Development; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Ethylenediamines; Humans; Isoniazid; Macrolides; Medication Adherence; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant

2019

Trials

3 trial(s) available for oxazolidin-2-one and isoniazid

ArticleYear
Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosis.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:4

    Topics: Acetamides; Animals; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Fluoroquinolones; Gatifloxacin; Isoniazid; Linezolid; Mice; Mice, Inbred C57BL; Oxazolidinones; Rifampin; Time Factors; Tuberculosis

2004
Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis.
    American journal of respiratory and critical care medicine, 2008, Dec-01, Volume: 178, Issue:11

    Topics: Acetamides; Adult; Antibiotics, Antitubercular; Colony Count, Microbial; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Linezolid; Male; Middle Aged; Oxazolidinones; Sputum; Tuberculosis, Pulmonary; Young Adult

2008
Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis.
    Antimicrobial agents and chemotherapy, 2022, 02-15, Volume: 66, Issue:2

    Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Sputum; Tuberculosis, Pulmonary; Young Adult

2022

Other Studies

14 other study(ies) available for oxazolidin-2-one and isoniazid

ArticleYear
3-Isoxazolidone--an inhibitor of GABA metabolism.
    Biochemical pharmacology, 1976, Jul-15, Volume: 25, Issue:14

    Topics: Aminobutyrates; Animals; Brain; Chickens; Depression, Chemical; GABA Antagonists; gamma-Aminobutyric Acid; Glutamate Decarboxylase; In Vitro Techniques; Isoniazid; Isoxazoles; Male; Mice; Oxazoles; Oxazolidinones; Rats; Seizures; Time Factors

1976
[Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
    Enfermedades infecciosas y microbiologia clinica, 2001, Volume: 19, Issue:1

    Topics: Acetamides; Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Clavulanic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Isoniazid; Linezolid; Mycobacterium bovis; Oxazolidinones; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2001
Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
    International journal of antimicrobial agents, 2005, Volume: 25, Issue:6

    Topics: Acetamides; Animals; Antitubercular Agents; Cell Line; Drug Antagonism; Furans; Isoniazid; Linezolid; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxazoles; Oxazolidinones; Rifampin

2005
In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:2

    Topics: Antitubercular Agents; Cells, Cultured; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Oxazolidinones; Rifampin

2006
[Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:2

    Topics: Acetamides; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Isoniazid; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Rifampin; Tuberculosis, Multidrug-Resistant

2009
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Acetamides; Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Discovery; Ethambutol; Fluoroquinolones; Immunocompetence; Inhalation Exposure; Isoniazid; Linezolid; Mice; Mice, Inbred C57BL; Moxifloxacin; Oxazolidinones; Pyrazinamide; Quinolines; Reproducibility of Results; Rifampin; Tuberculosis, Pulmonary

2010
Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3

    Topics: Acetamides; Antitubercular Agents; Ethambutol; Isoniazid; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant

2011
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
    The European respiratory journal, 2011, Volume: 38, Issue:3

    Topics: Acetamides; Adult; Amikacin; Antitubercular Agents; Capreomycin; Drug-Related Side Effects and Adverse Reactions; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Infectious Disease Medicine; Isoniazid; Kanamycin; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin

2011
Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant

2012
Prevalence and incidence of symmetrical symptomatic peripheral neuropathy in patients with multidrug-resistant TB.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2013, Oct-11, Volume: 104, Issue:1

    Topics: Humans; Incidence; Isoniazid; Isoxazoles; Oxazolidinones; Peripheral Nervous System Diseases; Prevalence; Tuberculosis, Multidrug-Resistant

2013
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 04-24, Volume: 68, Issue:9

    Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2019
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7

    Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis

2019
Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular
    Frontiers in cellular and infection microbiology, 2019, Volume: 9

    Topics: Adenosine Triphosphatases; Amides; Amino Acids; Antitubercular Agents; Cycloserine; Diarylquinolines; Drug Tolerance; Ethambutol; Ethionamide; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Host-Pathogen Interactions; Humans; Isoniazid; Isoxazoles; Metabolic Networks and Pathways; Models, Biological; Mycobacterium bovis; Mycobacterium tuberculosis; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis

2019
A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen.
    The American journal of case reports, 2022, Oct-10, Volume: 23

    Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Cutaneous Fistula; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Male; Meropenem; Micafungin; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Rifampin; Streptomycin; Teicoplanin; Tetrazoles; Tuberculosis

2022